California’s Most Vulnerable Patients Are Being Threatened

By | 2018-03-22T21:33:19+00:00 March 22nd, 2018|CIBD Clinic, CIBD News, Community News, Hemophilia, HTC news, Pharmaceutical News, Sickle Cell|

Healthcare Providers Urge Senate to Oppose Budget Proposal Eliminating 340B Drug Discount Program for Medi-Cal Patients In a press release dated March 22, 2018, the Center For Inherited Blood Disorders has reported that patients with Chronic and debilitating illnesses will suffer under Brown administration proposal to eliminate the 340B Discount Drug Program. Diane J. Nugent, [...]

New Method To Detect Antibodies Linked To Inhibitor Development

By | 2017-03-27T19:47:30+00:00 March 27th, 2017|CIBD News, Hemophilia|

KEY FINDINGS: New Method to Detect the Type of Antibodies Linked to Inhibitors Development Among People with Hemophilia A and B In an article release by the CDC (Center for Disease Control and Prevention), research reports key findings related to the formation of inhibitors (antibodies) in patients who have hemophilia. The study shows that hemophilia [...]

Engineers Develop First Ever Pill to Treat Hemophilia

By | 2016-12-08T06:03:11+00:00 December 8th, 2016|CIBD News, Hemophilia|

Researchers from The University of Texas at Austin have designed a capsule which carry a protein therapy that treats patients with hemophilia B. "There are approximately 400,000 people worldwide living with either hemophilia A or hemophilia B, both caused by a missing protein in their blood. Hemophilia B is caused by a missing or defective [...]